Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
FEBS Letters
|
July 26, 2005
The co-chaperone p23 is degraded by caspases and the proteasome during apoptosis
Jens Mollerup, Martin W Berchtold
Cancers
|
May 14, 2022
Companion Diagnostics and Predictive Biomarkers for MET-Targeted Therapy in NSCLC
Jan Trøst Jørgensen, Jens Mollerup
Cancers
|
October 28, 2023
The Different Roles of MET in the Development and Treatment of Cancer
Jens Mollerup, Jan Trøst Jørgensen
BMC Clinical Pathology
|
February 16, 2012
Dual color chromogenic in situ hybridization for determination of HER2 status in breast cancer: a large comparative study to current state of the art fluorescence in situ hybridization
Jens Mollerup, Ulla Henriksen, Sven Müller, et al.
Translational Lung Cancer Research
|
May 13, 2024
MET targeted therapy in non-small cell lung cancer patients with <i>MET</i> exon 14-skipping mutations
Jan Trøst Jørgensen, Edyta M Urbanska, Jens Mollerup
Biochemical and Biophysical Research Communications
|
January 12, 2007
ALG-2 oscillates in subcellular localization, unitemporally with calcium oscillations
Jonas M la Cour, Jens Mollerup, Martin Werner Berchtold
Frontiers in Bioscience : a Journal and Virtual Library
|
February 24, 2004
ALG-2, a multifunctional calcium binding protein?
Svetlana Tarabykina, Jens Mollerup, Pernille Winding, et al.
Archives of Pathology & Laboratory Medicine
|
July 31, 2010
Pathology economic model tool: a novel approach to workflow and budget cost analysis in an anatomic pathology laboratory
David Muirhead, Patricia Aoun, Michael Powell, et al.
FEBS Letters
|
December 17, 2003
Properties of the co-chaperone protein p23 erroneously attributed to ALG-2 (apoptosis-linked gene 2)
Jens Mollerup, Thomas N Krogh, Per F Nielsen, et al.
Annals of Translational Medicine
|
December 30, 2017
Detection of <i>MET</i> amplification in gastroesophageal tumor specimens using IQFISH
Jan Trøst Jørgensen, Karsten Bork Nielsen, Jens Mollerup, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
FEBS Letters
|
July 26, 2005
The co-chaperone p23 is degraded by caspases and the proteasome during apoptosis
Jens Mollerup, Martin W Berchtold
Cancers
|
May 14, 2022
Companion Diagnostics and Predictive Biomarkers for MET-Targeted Therapy in NSCLC
Jan Trøst Jørgensen, Jens Mollerup
Cancers
|
October 28, 2023
The Different Roles of MET in the Development and Treatment of Cancer
Jens Mollerup, Jan Trøst Jørgensen
BMC Clinical Pathology
|
February 16, 2012
Dual color chromogenic in situ hybridization for determination of HER2 status in breast cancer: a large comparative study to current state of the art fluorescence in situ hybridization
Jens Mollerup, Ulla Henriksen, Sven Müller, et al.
Translational Lung Cancer Research
|
May 13, 2024
MET targeted therapy in non-small cell lung cancer patients with <i>MET</i> exon 14-skipping mutations
Jan Trøst Jørgensen, Edyta M Urbanska, Jens Mollerup
Biochemical and Biophysical Research Communications
|
January 12, 2007
ALG-2 oscillates in subcellular localization, unitemporally with calcium oscillations
Jonas M la Cour, Jens Mollerup, Martin Werner Berchtold
Frontiers in Bioscience : a Journal and Virtual Library
|
February 24, 2004
ALG-2, a multifunctional calcium binding protein?
Svetlana Tarabykina, Jens Mollerup, Pernille Winding, et al.
Archives of Pathology & Laboratory Medicine
|
July 31, 2010
Pathology economic model tool: a novel approach to workflow and budget cost analysis in an anatomic pathology laboratory
David Muirhead, Patricia Aoun, Michael Powell, et al.
FEBS Letters
|
December 17, 2003
Properties of the co-chaperone protein p23 erroneously attributed to ALG-2 (apoptosis-linked gene 2)
Jens Mollerup, Thomas N Krogh, Per F Nielsen, et al.
Annals of Translational Medicine
|
December 30, 2017
Detection of <i>MET</i> amplification in gastroesophageal tumor specimens using IQFISH
Jan Trøst Jørgensen, Karsten Bork Nielsen, Jens Mollerup, et al.
Page
of 3